Literature DB >> 1601528

Striving for standards in bioequivalence assessment: a review.

H U Schulz1, V W Steinijans.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1601528

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN： 0174-4879


× No keyword cloud information.
  4 in total

1.  Tmax: an unconfounded metric for rate of absorption in single dose bioequivalence studies.

Authors:  R P Basson; B J Cerimele; K A DeSante; D C Howey
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  Relative bioavailability and pharmacodynamic effects of methantheline compared with atropine in healthy subjects.

Authors:  Christian Müller; Jörn Lötsch; Thomas Giessmann; Gerd Franke; Regina Walter; Michael Zschiesche; Werner Siegmund
Journal:  Eur J Clin Pharmacol       Date:  2012-04-21       Impact factor: 2.953

3.  Relative bioavailability of different oral sustained release oxprenolol tablets.

Authors:  S E Leucuta; M Follidis; R Capalneanu; A Mocan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

4.  Pharmacokinetics of carbamazepine. Part I: A new bioequivalency parameter based on a relative bioavailability trial.

Authors:  A Kayali; I Tuğlular; M Ertaş
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Oct-Dec       Impact factor: 2.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.